40 results
8-K
EX-99.1
ALLO
Allogene Therapeutics Inc
14 Mar 24
Allogene Therapeutics Reports Fourth Quarter and Full Year 2023
4:10pm
related to: changes in the macroeconomic environment or industry that impact our business; competition; risks related to third-party performance; our
8-K
ALLO
Allogene Therapeutics Inc
31 Jan 24
Entry into a Material Definitive Agreement
12:00am
others: changes in the macroeconomic environment or industry that impact the Company’s or Notch’s business; competition; the Company will not receive
8-K
yw0tsg g7ml6u
5 Jan 24
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
r9340690q
3 May 23
Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update
4:05pm
8-K
EX-99.1
7nolwpz4 q9fucf9
4 May 22
Allogene Therapeutics Reports First Quarter 2022 Financial Results
4:09pm
PRE 14A
bw8m4x8cciivpsdc7
14 Apr 22
Preliminary proxy
4:10pm